New studies show that first-generation COVID-19 vaccines effectively reduce severe disease but quickly lose their protective value.
In the context of the continuous emergence of SARS-CoV-2 coronavirus variants, and a potential fourth wave accelerating in Europe, these studies suggest enhancing COVID-19 vaccination coverage is still the most critical and urgent priority.
Read More
